Kevin Flyangolts
Kevin is founder and CEO of Aclid, a security and safety platform for biotechs. Aclid's platform helps biotechs comply with trade controls, international biosecurity and biosafety regulations, and federal funding requirements. The company works with DNA and RNA manufacturers in biosecurity, life sciences research labs in biosafety, and with US defense in biosurveillance.
Aclid
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 25th
Full Rate:
$3,495